Single-cell multiomics identifies Tcf1 and Lef1 as key initiators of early thymic progenitor fate
Science Immunology · 12.09.2025 · 10 (111)
DOI: 10.1126/sciimmunol.adq8970 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 12.09.2025. Verfasst von Xin Zhao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Zhejiang Key Laboratory of Medical Epigenetics, Department of Immunology and Pathogen Biology, School of Basic Medical Sciences, Hangzhou Normal Univ…. Hauptthemen laut MEDLINE: Lymphoid Enhancer-Binding Factor 1, Hepatocyte Nuclear Factor 1-alpha, Thymus Gland. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: BLRD VA, NIAID NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Bone marrow–derived multipotent hematopoietic progenitors seed the thymus and generate early thymic progenitors (ETPs). However, the factors governing ETP formation remain poorly defined. Using single-cell RNA sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin with sequencing (scATAC-seq), we dissected the heterogeneity of transcriptomic and chromatin accessibility landscapes in murine ETPs. Whereas Tcf1 − ETPs exhibited higher proliferative capacity, Tcf1 + ETPs appeared to be immediate, more robust precursors to T lineage–specified early thymocytes. Prethymic ablation of Tcf1 and its homolog Lef1 severely impaired ETP formation in vivo. Whereas ablating Tcf1 alone had limited impact, loss of both Tcf1 and Lef1 impaired transcriptional activation of Notch1 and Notch pathway effector molecules, including Hes1 and Hhex , accompanied by aberrantly induced B cell and myeloid gene programs. Acute deletion of both factors compromised Notch pathway, glycolysis, and T cell gene programs in emergent ETPs ex vivo. Thus, Tcf1 and Lef1 act upstream of the Notch pathway, functioning as prethymic initiators of ETP fate and intrathymic gatekeepers of ETP identity and T lineage potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Zhejiang Key Laboratory of Medical Epigenetics, Department of Immunology and Pathogen Biology, School of Basic Medical Sciences, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.
- Center for Discovery and Innovation, Hackensack University Medical Center, Nutley, NJ 07110, USA.
- Department of Genome Sciences, University of Virginia, Charlottesville, VA 22908, USA.
- UVA Comprehensive Cancer Center, University of Virginia, Charlottesville, VA 22908, USA.
- Center for Cutaneous Biology and Immunology Research, Department of Dermatology, Henry Ford Health System, Detroit, MI 48202, USA.
- Immunology Research Program, Henry Ford Cancer Institute, Henry Ford Health System, Detroit, MI 48202, USA.
ORCID-Profile: Xin Zhao, Shengen Shawn Hu, Wen-Han Lee, Johannes L Zakrzewski, Qing-Sheng Mi, Rachel K Rosenstein, Chongzhi Zang, Xiaoke Ma, Hai-Hui Xue
Förderung
- BLRD VA
- NIAID NIH HHS
- NCI NIH HHS
Zitieren
APA
Zhao, X., Hu, S. S., Lee, W. H., Zakrzewski, J. L., Mi, Q. S., Rosenstein, R. K., Zang, C., Ma, X., & Xue, H. H. (2025). Single-cell multiomics identifies Tcf1 and Lef1 as key initiators of early thymic progenitor fate. Science Immunology, 10(111). https://doi.org/10.1126/sciimmunol.adq8970
Vancouver
Zhao X, Hu SS, Lee WH, Zakrzewski JL, Mi QS, Rosenstein RK, et al. Single-cell multiomics identifies Tcf1 and Lef1 as key initiators of early thymic progenitor fate. Science Immunology. 2025;10(111). doi:10.1126/sciimmunol.adq8970
BibTeX
@article{Zhao2025,
author = {Zhao, Xin and Hu, Shengen Shawn and Lee, Wen-Han and Zakrzewski, Johannes L and Mi, Qing-Sheng and Rosenstein, Rachel K and Zang, Chongzhi and Ma, Xiaoke and Xue, Hai-Hui},
title = {Single-cell multiomics identifies Tcf1 and Lef1 as key initiators of early thymic progenitor fate},
journal = {Science Immunology},
year = {2025},
volume = {10},
number = {111},
doi = {10.1126/sciimmunol.adq8970}
}
EUVIMED